FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.4% | 98.3% | 98.4% | 98.6% | 98.5% | 99.7% | 99.4% | 99.8% | 98.3% | 97.4% | 96.9% | 98.7% | |
| 44.2% | 30.7% | 33.2% | 93.9% | 91.2% | 36.1% | 96.6% | 98.5% | 96.2% | 93.0% | 86.6% | 24.1% | |
| 96.5% | 95.2% | 95.1% | 93.9% | 91.2% | 94.8% | 96.6% | 98.5% | 96.2% | 93.0% | 86.6% | 96.5% | |
| – | – | – | – | – | – | – | – | 0.5% | 1.0% | 1.0% | – | |
| 15.6% | 9.4% | 10.4% | 35.0% | 47.8% | 14.8% | 19.0% | 8.5% | 13.4% | 26.3% | 37.4% | 10.7% | |
| 15.6% | 9.4% | 10.4% | 35.0% | 47.8% | 14.8% | 19.0% | 8.5% | 13.4% | 25.1% | 35.2% | 9.9% | |
| 11.2% | 3.7% | 5.3% | 20.2% | 28.7% | 7.9% | 10.6% | 4.9% | 5.7% | 12.1% | 19.5% | 6.8% | |
| 84.4% | 90.6% | 89.6% | 65.0% | 52.2% | 85.2% | 81.0% | 91.5% | 86.6% | 73.7% | 62.6% | 89.3% | |
| -235.3% | -304.1% | -393.4% | -530.9% | -818.2% | -250.2% | -357.5% | -167.8% | -204.5% | -269.8% | -365.2% | -130.7% | |
| 3.2% | 93.2% | 4.9% | 7.1% | 10.3% | 10.4% | 24.0% | 10.9% | 18.3% | 21.6% | 26.5% | 11.6% |
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.